NanoViricides, Inc. (NNVC)

1.185 -0.02 (-1.25%) USD  |  NYAM  |  Dec 24, 12:59
1.19 0.00 (0.00%) After-Hours: 13:59
More

NanoViricides SG&A Expense (TTM): 3.611M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NNVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
NovaBay Pharmaceuticals, Inc. 8.584M
Palatin Technologies, Inc. 7.449M
Theriva Biologics, Inc. 16.21M
Oragenics, Inc. 6.832M
Actinium Pharmaceuticals, Inc. 15.79M